The observed reduction in both CD73+ B-cell number and CD73 expression on B-cells in CRC tumors that underwent neoadjuvant therapy suggests that neoadjuvant therapy inhibited CD73 expression on B-cells. Here, NT5E is linked to colorectal carcinoma.